{"brief_title": "Intravenous Pertussis Immune Globulin in Patients With Severe Childhood Pertussis Infection", "brief_summary": "OBJECTIVES: Assess the efficacy of a single infusion of a high titer pertussis immune globulin for the treatment of severe pertussis in children.", "detailed_description": "PROTOCOL OUTLINE: This is a randomized, multicenter study. Patients are randomized to receive an infusion of either pertussis immune globulin or placebo (0.9% saline). Patients are followed every 2 weeks for up to 6 months. Completion date provided represents the completion date of the grant per OOPD records", "condition": ["Pertussis", "Whooping Cough"], "intervention_type": ["Drug"], "intervention_name": ["immune globulin"], "criteria": "- Documented infection with Bordetella pertussis", "gender": "All", "minimum_age": "N/A", "maximum_age": "5 Years", "healthy_volunteers": "No", "keyword": "rare disease", "mesh_term": ["Whooping Cough", "Immunoglobulins", "Antibodies", "gamma-Globulins", "Immunoglobulins, Intravenous", "Rho(D) Immune Globulin"], "id": "NCT00004422"}